Research programmes

Pharmaceutical biotechnology: Science for Health

Success in prevention, diagnosis and therapy depends on the knowledge on molecular mechanisms leading to the development and progression of disease. Our goal is to determine molecular targets for development of new diagnostic and therapeutic strategies in cancer, neurological and immune diseases. In cancer we will investigate the role of proteolytic enzymes, known promoters of tumour invasion and ...

31. December 2014 - 30. December 2018 | 4.06 Biotehniške vede

Genes, hormones and personality changes in metabolic disorders

Our programme is based on activities and achievements in the last two decades in the field of chronic metabolic disorders such as osteoporosis and bone metabolism, polycystic ovary syndrome (PCOS), diabetes type 2 (and to a lesser degree type 1) and insulin resistance as a common component of the last two disorders. The majority of our activities will be further research in the directions where we...

31. December 2014 - 30. December 2018 | 3.07 Metabolic and hormonal disorders

Medicinal chemistry - drug design, synthesis and evaluation

 The long-term goal of the research programme is discovery of new bioactive small molecules with a potential for development to drugs in important therapeutic areas through combined medicinal chemistry approaches. In the next period the research programme will focus on discovery and rational design of bioactive molecules exerting their action on validated drug targets, their synthesis and bio...

31. December 2014 - 30. December 2020 | 1.09 Pharmacy

Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly

Many scientific challenges exist with regards to development of original, generic and supergeneric drugs, which should be designed to treat patients of various populations. They will be solved using approaches which are designed to generate new knowledge for comprehensive therapy of children and eldery. In the field of development of novel dosage forms a concept of Quality by design will be follow...

31. December 2013 - 30. December 2017 | 1.09 Pharmacy